Land Stephanie R, Liu Qing, Wickerham D Lawrence, Costantino Joseph P, Ganz Patricia A
Authors' Affiliations: National Surgical Adjuvant Breast and Bowel Project (NSABP); Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh; Allegheny Cancer Center, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, Pennsylvania; Division of Cancer Control and Population Sciences, Behavioral Research Program, National Cancer Institute, Bethesda, Maryland; and UCLA Schools of Medicine and Public Health, and Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, California.
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):823-32. doi: 10.1158/1055-9965.EPI-13-1105-T. Epub 2014 Feb 25.
NSABP P-1 provides an opportunity to examine the association of behavioral factors with prospectively monitored cancer incidence and interactions with tamoxifen.
From 1992 to 1997, 13,388 women with estimated 5-year breast cancer risk greater than 1.66% or a history of lobular carcinoma in situ (87% younger than age 65; 67% postmenopausal) were randomly assigned to tamoxifen versus placebo. Invasive breast cancer, lung cancer, colon cancer, and endometrial cancer were analyzed with Cox regression. Predictors were baseline cigarette smoking, leisure-time physical activity, alcohol consumption, and established risk factors.
At median 7 years follow-up, we observed 395, 66, 35, and 74 breast cancer, lung cancer, colon cancer, and endometrial cancer, respectively. Women who had smoked were at increased risk of breast cancer (P = 0.007; HR = 1.3 for 15-35 years smoking, HR = 1.6 for ≥ 35 years), lung cancer (P < 0.001; HR = 3.9 for 15-35 years, HR = 18.4 for ≥ 35 years), and colon cancer (P < 0.001; HR = 5.1 for ≥ 35 years) versus never-smokers. Low activity predicted increased breast cancer risk only among women assigned to placebo (P = 0.021 activity main effect, P = 0.013 activity-treatment interaction; HR = 1.4 for the placebo group) and endometrial cancer among all women (P = 0.026, HR = 1.7). Moderate alcohol (>0-1 drink/day) was associated with decreased risk of colon cancer (P = 0.019; HR = 0.35) versus no alcohol. There were no other significant associations between these behaviors and cancer risk.
Among women with elevated risk of breast cancer, smoking has an even greater impact on breast cancer risk than observed in past studies in the general population.
Women who smoke or are inactive should be informed of the increased risk of multiple types of cancer.
NSABP P-1研究提供了一个机会,来检验行为因素与前瞻性监测的癌症发病率之间的关联,以及与他莫昔芬的相互作用。
1992年至1997年,13388名预计5年乳腺癌风险大于1.66%或有小叶原位癌病史的女性(87%年龄小于65岁;67%为绝经后女性)被随机分配至他莫昔芬组或安慰剂组。采用Cox回归分析浸润性乳腺癌、肺癌、结肠癌和子宫内膜癌。预测因素为基线吸烟情况、休闲时间体力活动、饮酒情况以及已确定的风险因素。
在中位7年的随访中,我们分别观察到395例、66例、35例和74例乳腺癌、肺癌、结肠癌和子宫内膜癌。与从不吸烟者相比,曾经吸烟的女性患乳腺癌(P = 0.007;15 - 35年吸烟史者的风险比[HR] = 1.3,≥35年吸烟史者的HR = 1.6)、肺癌(P < 0.001;15 - 35年吸烟史者的HR = 3.9,≥35年吸烟史者的HR = 18.4)和结肠癌(P < 0.001;≥35年吸烟史者的HR = 5.1)的风险增加。低体力活动仅在分配至安慰剂组的女性中预测乳腺癌风险增加(体力活动主效应P = 0.021,体力活动与治疗的交互作用P = 0.013;安慰剂组的HR = 1.4),在所有女性中预测子宫内膜癌风险增加(P = 0.026,HR = 1.7)。中度饮酒(>0 - 1杯/天)与不饮酒相比,结肠癌风险降低(P = 0.019;HR = 0.35)。这些行为与癌症风险之间没有其他显著关联。
在乳腺癌风险升高的女性中,吸烟对乳腺癌风险的影响比过去在一般人群中的研究观察到的更大。
应告知吸烟或缺乏体力活动女性多种癌症风险增加的情况。